7/21/2016

Tamsulosin Hydrochloride

Products Affected - Description

- Tamsulosin Hydrochloride capsule, Mylan, 0.4 mg, unit-dose 25 count, NDC 00378-0294-19

Reason for the Shortage

- Boehringer Ingelheim had tamsulosin capsules on shortage due to production delays.
- Actavis and Zydus state the reason for the shortage was increased demand.
- Aurobindo is not marketing the 100 count size.
- Caraco cannot provide a reason for the shortage.
- Teva discontinued tamsulosin 0.4 mg capsules in April 2014.
- Par discontinued tamsulosin 0.4 mg capsules.
- Sandoz has tamsulosin on shortage due to increased demand for the product.
- Mylan discontinued tamsulosin 0.4 mg capsules 25 count unit-dose presentations in mid-2016.

Available Products

- Flomax capsule, Boehringer Ingelheim, 0.4 mg, 100 count, NDC 00597-0166-01
- Tamsulosin Hydrochloride capsule, Actavis, 0.4 mg, 100 count, NDC 00228-2996-11
- Tamsulosin Hydrochloride capsule, Actavis, 0.4 mg, 500 count, NDC 00228-2996-50
- Tamsulosin Hydrochloride capsule, Aurobindo, 0.4 mg, 500 count, NDC 65862-0598-05
- Tamsulosin Hydrochloride capsule, Caraco, 0.4 mg, 90 count, NDC 62756-0160-81
- Tamsulosin Hydrochloride capsule, Caraco, 0.4 mg, 100 count, NDC 62756-0160-88
- Tamsulosin Hydrochloride capsule, Caraco, 0.4 mg, 500 count, NDC 62756-0160-13
- Tamsulosin Hydrochloride capsule, Citron Pharma, 0.4 mg, 100 count, NDC 57237-0014-01
- Tamsulosin Hydrochloride capsule, Citron Pharma, 0.4 mg, 500 count, NDC 57237-0014-05
- Tamsulosin Hydrochloride capsule, Mylan, 0.4 mg, 90 count, NDC 00378-2500-77
- Tamsulosin Hydrochloride capsule, Mylan, 0.4 mg, unit-dose 100 count, NDC 00378-0294-20
- Tamsulosin Hydrochloride capsule, Mylan, 0.4 mg, unit-dose 300 count, NDC 00378-0294-56
- Tamsulosin Hydrochloride capsule, Mylan, 0.4 mg, 1000 count, NDC 00378-2500-10
- Tamsulosin Hydrochloride capsule, Sandoz, 0.4 mg, 100 count, NDC 00781-2076-01
- Tamsulosin Hydrochloride oral capsule, Zydus, 0.4 mg, 100 count, NDC 68382-0132-01
- Tamsulosin Hydrochloride oral capsule, Zydus, 0.4 mg, 1000 count, NDC 68382-0132-10

Estimated Resupply Dates

- All marketed presentations are available.

Updated

Updated July 21, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 17, 2014 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.